Your browser doesn't support javascript.
loading
Human Cytomegalovirus Infection and Neurocognitive and Neuropsychiatric Health.
Gale, Shawn D; Farrer, Thomas J; Erbstoesser, Reagan; MacLean, Scott; Hedges, Dawson W.
Afiliação
  • Gale SD; The Department of Psychology, Brigham Young University, Provo, UT 84602, USA.
  • Farrer TJ; The Neuroscience Center, Brigham Young University, Provo, UT 84602, USA.
  • Erbstoesser R; Idaho WWAMI Medical Education Program, University of Idaho, Moscow, ID 83844, USA.
  • MacLean S; The Department of Biology, Brigham Young University, Provo, UT 84602, USA.
  • Hedges DW; The Department of Psychology, Brigham Young University, Provo, UT 84602, USA.
Pathogens ; 13(5)2024 May 16.
Article em En | MEDLINE | ID: mdl-38787269
ABSTRACT
A common infection, human cytomegalovirus (HCMV) has been associated with a variety of human diseases, including cardiovascular disease and possibly certain cancers. HCMV has also been associated with cognitive, psychiatric, and neurological conditions. Children with congenital or early-life HCMV are at risk for microcephaly, cerebral palsy, and sensorineural hearing loss, although in many cases sensorineural loss may resolve. In addition, HCMV can be associated with neurodevelopmental impairment, which may improve with time. In young, middle-aged, and older adults, HCMV has been adversely associated with cognitive function in some but not in all studies. Research has linked HCMV to Alzheimer's and vascular dementia, but again not all findings consistently support these associations. In addition, HCMV has been associated with depressive disorder, bipolar disorder, anxiety, and autism-spectrum disorder, although the available findings are likewise inconsistent. Given associations between HCMV and a variety of neurocognitive and neuropsychiatric disorders, additional research investigating reasons for the considerable inconsistencies in the currently available findings is needed. Additional meta-analyses and more longitudinal studies are needed as well. Research into the effects of antiviral medication on cognitive and neurological outcomes and continued efforts in vaccine development have potential to lower the neurocognitive, neuropsychiatric, and neurological burden of HCMV infection.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article